Basic Information
| LncRNA/CircRNA Name | FGF13-AS1 |
| Synonyms | NA |
| Region | GRCh38_X:138711452-138716617 |
| Ensemble | ENSG00000226031 |
| Refseq | NR_038405 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, Luciferase reporter assay, RIP, Western blot |
| Sample | breast cancer tissue,cell line |
| Expression Pattern | down-regulated |
| Function Description | In this study, we report that FGF13-AS1 expression is decreased in breast cancer tissue compared with corresponding normal tissue, and the downregulation of FGF13-AS1 is associated with poor prognosis. |
| Pubmed ID | 30771425 |
| Year | 2019 |
| Title | Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop. |
External Links
| Links for FGF13-AS1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |